Cardiovascular effects of rilmenidine, a new alpha 2-adrenoceptor agonist, and clonidine in conscious spontaneously hypertensive rats. 1989

F Sannajust, and C Julien, and C Barrès, and C Cerutti, and E Koenig-Bérard, and J Sassard
Department of Physiology and Clinical Pharmacology, Faculty of Pharmacy, Lyon, France.

1. The acute and chronic effects of rilmenidine, a partial agonist of alpha 1- and alpha 2-adrenoceptors with antihypertensive properties, were compared to those of clonidine on blood pressure (BP), heart rate (HR) and the urinary excretion of catecholamines, which was used as an index of sympathetic activity. 2. As these drugs are known to interfere centrally and peripherally with the sympathetic nervous system, long-term arterial blood pressure recordings in freely moving unstressed adult spontaneously hypertensive rats (SHR) were used. 3. Acute i.v. administrations of rilmenidine (0.3 mg/kg at 1200 h, 1.2 mg/kg at 1700 and 2200 h) and clonidine (12 micrograms/kg at 1200 h, 50 micrograms/kg at 1700 and 2200 h) induced short-lasting increases in BP associated with a decrease in HR, which were followed by prolonged, dose-dependent decreases in BP without bradycardia. The pressor effect was less marked and the associated bradycardia was more marked in active SHR with physiologically high sympathetic activity than in resting SHR. 4. A 12-day oral treatment with rilmenidine (6.0 mg/kg daily) or clonidine (150 micrograms/kg daily) induced moderate decreases in BP without change in HR. Rilmenidine but not clonidine decreased normetanephrine (NMN) excretion in active but not in resting SHR. 5. Finally, during the 24 h following the cessation of the treatments, BP returned to normal, without significantly exceeding that of untreated controls. However, upswings in BP or HR were observed, more markedly and frequently after clonidine than after rilmenidine. 6. In conclusion the effects of alpha 2-adrenoceptor agonists appear to be influenced by the pre-existing sympathetic tone. The general agreement between these data and those observed in patients demonstrates that the use of conscious unstressed animals is of value to determine the cardiovascular effects of drugs which act on the sympathetic nervous system.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000077769 Rilmenidine Oxazole derivative that acts as an agonist for ALPHA-2 ADRENERGIC RECEPTORS and IMIDAZOLINE RECEPTORS. It is used in the treatment of HYPERTENSION. 2-(N-(Dicyclopropylmethyl)amino)oxazoline,2-(N-(Dicyclopropylmethyl)amino)oxazoline Phosphate Salt,Hyperium,Oxaminozoline,Rilmenidine Phosphate,S 3341,S-3341,S-3341-3,S3341,S 3341 3,S33413

Related Publications

F Sannajust, and C Julien, and C Barrès, and C Cerutti, and E Koenig-Bérard, and J Sassard
July 1992, Japanese journal of pharmacology,
F Sannajust, and C Julien, and C Barrès, and C Cerutti, and E Koenig-Bérard, and J Sassard
January 1991, Fundamental & clinical pharmacology,
F Sannajust, and C Julien, and C Barrès, and C Cerutti, and E Koenig-Bérard, and J Sassard
March 1992, British journal of pharmacology,
F Sannajust, and C Julien, and C Barrès, and C Cerutti, and E Koenig-Bérard, and J Sassard
December 1989, Journal of veterinary pharmacology and therapeutics,
F Sannajust, and C Julien, and C Barrès, and C Cerutti, and E Koenig-Bérard, and J Sassard
March 1986, The Journal of pharmacology and experimental therapeutics,
F Sannajust, and C Julien, and C Barrès, and C Cerutti, and E Koenig-Bérard, and J Sassard
February 1988, The American journal of cardiology,
F Sannajust, and C Julien, and C Barrès, and C Cerutti, and E Koenig-Bérard, and J Sassard
February 1988, The American journal of cardiology,
F Sannajust, and C Julien, and C Barrès, and C Cerutti, and E Koenig-Bérard, and J Sassard
March 1999, British journal of pharmacology,
F Sannajust, and C Julien, and C Barrès, and C Cerutti, and E Koenig-Bérard, and J Sassard
November 2007, British journal of pharmacology,
F Sannajust, and C Julien, and C Barrès, and C Cerutti, and E Koenig-Bérard, and J Sassard
January 1986, Clinical and experimental hypertension. Part A, Theory and practice,
Copied contents to your clipboard!